Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 86.42 million compared to CNY 89.2 million a year ago. Net loss was CNY 5.88 million compared to CNY 6.04 million a year ago.

Basic loss per share from continuing operations was CNY 0.0031 compared to CNY 0.00319 a year ago.